+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID01659203

Phase III Trial of Pre-Operative Proton or Photon Radiation Therapy with Boosted Dose to High-Risk Areas in Retroperitoneal Sarcomas

Led by Massachusetts General Hospital · Updated on 2026-07-31

80

Participants Needed

10

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

This research is a Phase III clinical trial studying retroperitoneal sarcomas, which are soft tissue tumors located in the far back of the abdomen. The trial aims to determine the highest safe dose of radiation therapy using proton beam radiation or intensity-modulated radiation therapy IMRT and to evaluate the effectiveness of proton beam radiation for patients with this condition. Researchers are exploring these targeted radiation methods to reduce side effects compared to conventional radiation therapy. Participants will receive either proton beam radiation therapy IG-IMPT or photon radiation therapy IG-IMRT daily from Monday to Friday over about six weeks before surgery to remove the tumor. A standard radiation dose will be delivered to most of the tumor, while a higher dose boost will be given to higher-risk tumor areas. Radiation planning involves CT scans to guide treatment. After radiation, participants will undergo surgery to remove their tumors. During the study, participants will have weekly visits to monitor side effects and health during radiation therapy. Before surgery, imaging scans and blood tests will assess overall health and treatment effects. Follow-up visits occur within one month after surgery and again four months later, including assessments and scans. Long-term follow-up includes visits twice yearly for five years and annually thereafter to monitor health and disease status. The primary outcomes include determining the maximum tolerated radiation dose and the local control rate over two years.

CONDITIONS

Brief Title

Proton or Photon RT for Retroperitoneal Sarcomas

Research Team

T

Thomas DeLaney, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here